William W. Ericson, Director, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 119,556 shares at $18.02 ($2.2M) on 2015-05-29, disclosed to the SEC on 2015-06-01.
Scheduled sale ($2.2M) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.02 | 7,483 | $135K | 6.3% |
| 2 | $18.02 | 112,073 | $2.0M | 93.7% |
| Total | $18.02 avg | 119,556 | $2.2M | 100% |
| Filing → |
| ADMS | BUY | 2016-09-16 | $2.1M | — | Filing → |
| ADMS | BUY | 2016-09-14 | $2.6M | — | Filing → |
| ADMS | BUY | 2016-09-09 | $1.9M | — | Filing → |